- Molecular Imaging
- PET Imaging
- Nuclear Medicine
- +۵ مورد دیگر
Arion-Xenofon Fokion Hadjioannou, Ph.D. serves as Professor, Department Vice Chair, and Director of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) School of Medicine. He holds the prestigious Crump Chair in Medical Engineering, reflecting his significant contributions to the field of medical imaging technology development at one of the world's leading research institutions. Dr. Hadjioannou's research spans multiple disciplines including Molecular Imaging , Nuclear Medicine , Biomedical Engineering , and Medical Physics . His expertise focuses on PET technology development specifically for preclinical applications with small animal models. His work has advanced detector technology, image reconstruction algorithms, and multimodal imaging approaches that combine PET with optical imaging systems (OPET), enabling more comprehensive visualization of biological processes at the molecular level. Analysis of Dr. Hadjioannou's publication record from 2000-2005 reveals a consistent trajectory of innovation in molecular imaging instrumentation. His research progressed from fundamental detector development to sophisticated multimodal imaging systems, with particular emphasis on achieving high-resolution imaging for small animal studies. His publications in high-impact journals like IEEE Transactions on Nuclear Science and European Journal of Nuclear Medicine demonstrate technical expertise that has influenced the field of preclinical imaging. Among his notable achievements is the Crump Chair in Medical Engineering, an endowed position recognizing exceptional contributions to medical engineering. His work has been referenced in multiple patents and has garnered significant attention in the scientific community, as evidenced by citation metrics across his publications. Dr. Hadjioannou has established productive collaborations with leading researchers including Simon Cherry at UC Davis and Richard Leahy at USC. These partnerships have extended the impact of his work beyond UCLA, contributing to the broader development of microPET technology that has become essential for preclinical research worldwide. His leadership as Department Vice Chair and Director positions him at the forefront of shaping research directions in molecular and medical pharmacology.






